Animal cells 'talk' or communicate with each other in a variety of ways. In tissues and organs, cells communicate directly via plasma membrane specializations called gap junctions. structures that incorporate a transmembrane channel through which cytoplasmic molecules and ions up t o about 1000 Da pass (Fig. I (1-c) . G a p junctions are widespread across phyla, and. with the exception o f arthropoda. are regarded a s morphologically constant membrane specializations. Biochemical characterization o f gap junctions. following their initial isolation in the early 1970s from liver homogcnates I 1-31, has been severely hindered by the proclivity of their protein constituents t o undergo proteolysis during isolation and aggregation during analysis. but there is now general consensus that gap junctions are relatively simple organelles constructed o f ii major polypeptide that shows extensive immunological and biochemical similarities in various tissues and species 14-61.
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In liver tissue. the major gap junction polypeptide is a 32 kDa polypeptide 17-101. A variety of experimental approaches have accrued t o support the view that this 32 kDa polypeptide is the principal channel-forming constituent in rat liver. Polyclonal and monoclonal antibodies to this polypeptide were shown. by electron microscopy, to immunolocalize at gap junctions i ' e sections in cryostat and Lowicryl sections j 1 I -13 I.
ty-purified antibodies t o this 32 kDa polypeptide. when injected into embryonic cells I 141 o r hepatocytes I 15 1 , blocked intercellular communication assessed by dye transfer and electrical resistance measurements. Reconstitution of the 32 kDa polypcptide into lipid bilayers produced channels that were sensitive to changes in pH and Ca:' concentration, a propcrty of gap junctions in tissues 1161. A further independent line of evidence in support of the candidacy of the 32 kDa polypeptide comes from experiments in which oocytes injected with an mRNA corresponding to the protein were shown t o translate the message leading t o the production of intercellular channels [ I7 1 .
The gap junctions of heart [ 181 and lens [ 191 are composed of larger. but relatcd, channel-forming polypeptides of 43 kDa and 70 kDa, respectively. T h e 4 3 kDa polypeptide displays extensive sequence similarity to the liver protein and is thought t o adopt a similar topological arrangement in the lipid bilayer. T h e full sequence of the 70 kDa lens polypeptide has not been determined. but partial sequencing o f the N-terminus has demonstrated sequency similarity t o other members of the gap junction family. Complementary DNAs t o the two X e r q m s embryonic gap junction polypeptides of 30 and 38 kDa have been described 120.211, and analysis of the deduced primary sequcnccs comply with, and reinforce. the patterns emerging from studies with the 4 3 and 32 kDa polypeptides of heart and liver.
In rat liver, the major constituent of gap junctions was first partially sequenced by chemical methods. but the full sequence of the 32 kDa polypeptide was deduced from a cDNA clone of human or rat liver [22, 2.31 . A low-resolution model was proposed (Fig. I d ) in which the polypeptide traverses the plasma membrane lipid bilayer four times, with the N-and (-termini located at the membrane's cytoplasmic face j24J. This model was proposed on the basis of ( a ) the hydrophobicity plots of the complete amino acid sequence as deduced from the cDNA sequence, ( h ) the analysis using antibodies t o the N-and ('-terminal regions of Larious fragments released from intact and 'split' junctions by treatment with trypsin and specific endopeptidases, and ( c ) the application of microsequencing to the peptide fragments released from and retaincd in the mcmbranc. No proteasc c1c;ivagc could be induced in the loop sequences connecting the first/ second and third/fourth transmembrane sequence, suggesting that these two loops are located in the intercellular gap. Further evidence in support of this model has since been produced by the application of specific proteases and sitcspecific antibodies for the liver 32 kDa 125, 261 a s wcll :is the heart 43 kDa polypeptide 1271. In ; i further refinement of thc modcl, it has been argucd that the third transmembrane helix (amino acid residues 130-1 SO), in view of it containing polar amino acids bordered by a high proportion of aromatic amino acids. a property conserved bctwcen the polypeptides of humans, rats and Xeriopirs, is suggestive that this region of the sequence contributes t o the wall of the channel extending through the junction 128I.
To establish turther the molecular details of currcnt models which advocate a common folding pattern in the plasma membrane for the gap junction polypcptide family, we have prepared antibodies to nine peptides accounting for 127 amino acids of the 283 residues in the liver sequence, of which approx 200 residues are exposed to the cytoplasmic or extracellular 'gap' regions. Many of thc antibodies produced in rabbits to these various synthetic polypeptides, covalently attached to haemocyanin, were able t o recognize the peptides, but were unable to recognize satisfactorily thc gap junction polypeptide or gap junctions in tissue sections by Western blotting or immunocytochemistry, respectively. However, four anti-peptide antibodies have been generated that recognized the gap junction structures and proteins, and these have proven useful for structural and functional studies. Their properties and potential use are now reviewed.
Antibodies t o peptide Gap-3 (amino acid residues 6-2 I ) were demonstrated to cross-react with rat liver, heart and uterus 161. This result, taken with the data obtained with antibodies to thc total protein [ 5 1, indicates that immunological reactivity between tissues and across species exists, and that similar amino acid sequences that lead to similar conformational states of the protein occur widely. Antibodies t o pcptidc Gap-3 were also used to demonstrate. in conjunction with other approaches described above, that the N-terminus of the polypeptide was probably located at the membrane's cytoplasmic face 1241. Antibodies to peptide Des-1. constructed from two closely aligned scqucnces in the intracellular loop that contain a high frequency of basic amino acids (amino acid residues 102-1 12, I 16-I24), immunoprecipitated the 32 kDa gap junction polypeptide from rat liver membranes, and were demonstrated t o immunolocalizc to isolated intact and split gap junctions in a manner supporting the model (S. Rahman & W. H. Evans, unpublished work). Antibodies to peptide Gap-7 (amino acid residues 46-59) have proven useful for investigating the distribution of gap junctions in various tissues and species, for it is emerging that the two extracellular loops of gap junction polypeptides arc the most highly conserved amino acid sequence regions in the gap junction family. This antipeptide antiserum directed against external epitopes is currently being used t o study the consequences of the inhibition of the rapid formation of gap junctions between homotypic and heterotypic cells in culture. Finally, antibodies to peptide G a p 4 (amino acid residues 263-283), located at the C-terminus of the rat liver polypeptide, are also proving invaluable for detecting immunological cross-reactivity of gap junction polypeptides across species and between tissues. Since the demonstration that rodent livcrs contain, in addition t o the 32 kDa polypeptide, a lower amount of an . is believed t o be an assembly of 32 kDa polypeptides with the topographical arrangement such that the N-and C-termini are exposed at the cytoplasmic face of the plasma membrane. In ((1). a detailed arrangcmcnt of the amino acid sequence o f the 32 kDa liver polypcptide in the membrane is shown. T h e amino acid sequence t o which antibodies are generated are shown.
homologous truncated 26 kDa polypeptide that lacks the extended cytoplasmic tail shown in Fig. 1 [ 30, 3 1 ) , this Gap-9 antibody. in conjunction with antibodies to Gap-7 described above. is bcing used t o investigate the presence and variations in the molecular sizes of the polypeptides in various tissues and organs. T h e cytoplasmic tail region of the 32 kDa gap junction polypeptide is the domain subject to phosphorylation. and it is hypothesized that phosphorylation. demonstrated on w i n e residues 132, 331. is involved in the regulation of gap junction permeability.
A further approach. involving the application of the sitedirected antibodies described above, is the delineation of the biogenic routes followed by gap junction polypeptides and possible precursors as they migrate from their site of synthesis to the plasma membrane before assembly into functional and morphologically recognizable gap junctions. the latter process being energy independent. T h e gap junction polypeptide isolated from junction-enriched fractions is not glycosylated: for example, an unused consensus N-glycosylation sequence is located at residues 2-5 at the cytoplasmic side o f the membrane near the N-terminus. Analysis of the distribution of the 32 kDa polypeptide among Golgi, lysosomal, endosomal and plasma membrane fractions of rat liver 134) indicated that its electrophoretic migration in SDS/ polyacrylamide gels is constant among these subcellular fractions originating from membranes comprising cxocytic and endocytic traffic routes. thus suggesting that extensive glycosylation, that would have resulted in a lowered electrophoretic migration, had not occurred 1291. Preliminary data in which various endoglycosidasc treatments o f the fractions have been employed also indicate that no changes in electrophoretic mobility in Golgi and post-Golgi membrane fractions wcre detected (S. Rahman & W. H. Evans. unpublished work), therefore reinforcing the view that the gap junction protein in liver is not subject t o glycosylation during its movement through the Golgi apparatus.
A functional approach open to investigation with these antibodies specific to epitopes at the external and internal loops and cytoplasmic tails of the gap junction protein is their use to manipulate and block intercellular communication and to explore the developmental consequences. Established studies using affinity-purified antibodies to the 32 kDa polypeptide have demonstrated that blockagc of communication in Xeriopirs 1141 and mouse 1351 embryos resulted in developmental irregularities; these are direct demonstrations of the roles of gap junctions in development 136, 37). The site-specific antibodies t o gap junction epitopes now described provide new opportunities t o examine the crucial domains of the protein that are involved in the regulation of intercellular communication.
itroclir ctior i
Cytotoxic T lymphocytes (CTL) arc involved in the recognition and lysis of virus-infected or otherwise modified cells. They recognize processed foreign antigens expressed on the surface of target cells in association with maior histocompatibility complex ( M H C ) antigens. Multiple cell surface molecules contribute t o the interaction of CTL with their In this communication, the role of CD8 as an adhesion molecule has been examined in two experimental systems. First, it was shown that HLA-B27-specific human CTL clones with similar fine specificity were able to kill murine transfcctant cells expressing this antigen only when the effector cell was of sufficiently high avidity. T h e lysis of these tranSfectantS was critically dependent CD8. Secondly, alloreactive CTL clones with dual specificity for HLA-B27 and HLA-DR2 were used to show a differential role of CD8 in their class I-or class II-directed cytotoxicity. target cells. In the first step. non-specific conjugates are established. involving the T-cell LFA-1, CD2 and CD4 or CD8 molecules and their corresponding ligands on the target cell. In the second step, stable conjugates are formed after the interaction o f the T-cell antigen receptor with its specific antigenic determinant on the targct cell [ 11. T h e formation of stable conjugates leads t o target cell lysis.
Most CTL that recognize class I MHC antigens display thc CD4-CDX' phenotype. whcreas those that recognize class II antigens are usually CD3' CUX-. There is strong evidence that CD8 contributes to the formation of stable 
